Pharmaceutical
ChemLinkedChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
News
Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
INDUSTRY
Marketing Approval Innovative Drug Diabetes Drug Registration New Drug
[Updated] GLP-1-RAs Swoop to Chinese Market, Eyeing Diabetes Treatment & Weight Control Needs On July 25, 2023, China National Medical Products Administration (NMPA) approved Beinaglutide Injection (Feisumei), a glucagon-like peptide-1 receptor agonist (GLP-1-RA), for weight loss.
Jan 09, 2024
INDUSTRY
Marketing Approval Priority Review Cancer New Drug
Monthly Report: New Drug Approvals in China | December 2023 In Dec 2023, China NMPA approved 8 new drugs, among which 6 are chemical drugs and 2 are biological products.
Jan 02, 2024
INDUSTRY
Marketing Approval Priority Review Innovative Drug Generic Drug Drug Registration
Monthly Report: New Drug Approvals in China | November 2023 In Nov 2023, China NMPA approved 20 new drugs, among which 15 are chemical drugs and 5 are biological products.
Nov 30, 2023
INDUSTRY
Marketing Approval Innovative Drug Generic Drug Biological Product Cancer Rare Disease Drug Registration New Drug Respiratory Disease
Monthly Report: New Drug Approvals in China | October 2023 In Oct 2023, China NMPA approved 15 new drugs, among which 12 are chemical drugs and 3 are biological products: 1. BMS’ Deucravacitinib Tablets (SOTYKTU); 2. Pfizer’s Ritlecitinib Tosylate Capsules (LITFULO); 3. Janssen-Cilag International’s Rilpivirine Injection; 4. Luye Pharma’s Rivastigmine Twice Weekly Transdermal Patch; 5. Abbvie’s Upadacitinib Sustained-release Tablets (RINVOQ)...
Nov 06, 2023
INDUSTRY
Priority Review Innovative Drug Generic Drug Biological Product Cancer Diabetes Rare Disease Drug Registration
Monthly Report: New Drug Approvals in China | September 2023 In Sept. 2023, China NMPA approved 19 new drugs, among which 12 are chemical drugs and 7 are biological products: 1. Luye Life Sciences’ Goserelin Microspheres for Injection 2. HRA Pharma Rare Diseases’ Mitotane Tablets 3. N.V. Organon’s Ezetimibe and Atorvastatin Calcium Tablets 4. Napp Pharmaceuticals’ Fluticasone Propionate and Formoterol Fumarate Aerosol for Inhalation 5. Sinotau Pharmaceuticals’ Florbetaben [¹⁸F] Injection (Ouweining) 6. Grand Pharma’s Carglumic Acid Dispersible Tablets (Anweide) 7. CSPC Ouyi Pharmaceutical’s Irinotecan Hydrochloride Liposome Injection 8. Qilu Pharmaceutical’s Dolutegravir Sodium Tablets 9. Gowell Pharma’s ω-3 Fish Oil Fat Emulsion Injection 10. Acebright Pharma’s Neratinib Maleate Tablets 11. Brilliant Pharmaceuticals’ Dacomitinib Tablets 12. Grand Life Sciences’ Etomidate Injectable Emulsion 13. Shanghai JMT-Bio Technology’s Narlumosbart Injection 14. Henlius’ Serplulimab Injection (Hansizhuang) 15. Eli Lilly’s Insulin Lispro Injection (Youmile) 16. Sanofi’s Dupilumab Injection (Dupixent) 17. Eli Lilly’s Dulaglutide Injection (TRULICITY) 18. MSD’s Pembrolizumab Injection (Keytruda) 19. Novartis’ Erenumab Injection (Aimovig)
Oct 09, 2023
INDUSTRY
Marketing Approval Innovative Drug Generic Drug Biological Product Drug Registration New Drug
Monthly Report: New Drug Approvals in China | August 2023 In Aug. 2023, China NMPA approved 17 new drugs, among which 14 are chemical drugs and 3 are biological products.
Sep 07, 2023
INDUSTRY
Marketing Approval Priority Review Generic Drug Diabetes Drug Registration New Drug
Monthly Report: New Drug Approvals in China | July 2023 In July 2023, China NMPA approved 5 new drugs, among which 3 are chemical drugs and 2 are biological products.
Aug 03, 2023
INDUSTRY
Marketing Approval Priority Review Innovative Drug Generic Drug Biological Product Cancer Diabetes Drug Registration New Drug
Monthly Report: New Drug Approvals in China | June 2023 In June 2023, China NMPA approved 33 new drugs, among which 26 are chemical drugs while 7 are biological products.
Jul 07, 2023
INDUSTRY
Guideline CMC
BaiPharm Shares Insights into Computational Toxicology at CPHI China As CPHI China’s partner, BaiPharm staged a seminar “Application of Computational Toxicology in the Pharmaceutical Industry” which covers four sessions, each presented by experienced experts, on June 19, 2023.
Jun 25, 2023
INDUSTRY
Marketing Approval Innovative Drug Generic Drug Biological Product Cancer Diabetes Vaccine Drug Registration New Drug
Monthly Report: New Drug Approvals in China | May 2023 In May 2023, China NMPA approved 27 new drugs, among which 16 are chemicals and 11 are biologics: 1. Betta Pharma’ Befotertinib Mesylate Capsules; 2. Sanhome Pharma’s Alfosbuvir Tablets; 3. Novartis’ Ribociclib Succinate Tablets...
Jun 12, 2023
Pre 12345 ...9 Next
Most Popular